Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis (Q35904466)

11 August 2017

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis (English)

1 reference

11 August 2017

0 references

1 reference

Johannes S.a.g. Schouten

4

object named as

J S Schouten

1 reference

11 August 2017

R J Erckens

1

1 reference

11 August 2017

R L M Mostard

2

1 reference

11 August 2017

P A H M Wijnen

3

1 reference

11 August 2017

M Drent

5

1 reference

11 August 2017

language of work or name

1 reference

27 November 2011

1 reference

Graefe's Archive for Clinical and Experimental Ophthalmology

11 August 2017

1 reference

11 August 2017

250

1 reference

11 August 2017

5

1 reference

11 August 2017

713-720

1 reference

https://scigraph.springernature.com/pub.10.1007/s00417-011-1844-0

11 August 2017

0 references

cites work

International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Anti-TNF-alpha therapy for sight threatening uveitis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Ocular involvement in sarcoidosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Prognosticators for visual outcome in sarcoid uveitis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Fatigue in sarcoidosis: American versus Dutch patients

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Treatment of therapy-resistant sarcoidosis with adalimumab.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Infliximab for refractory sarcoidosis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332360

Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one-year randomized controlled trial comparing systematic versus on-demand treatment

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00417-011-1844-0

21 January 2018

Treatment of sarcoidosis

1 reference

12 December 2020

Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept

1 reference

12 December 2020

C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis

1 reference

12 December 2020

Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis

1 reference

12 December 2020

A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism

1 reference

12 December 2020

Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15)

1 reference

12 December 2020

An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease

1 reference

12 December 2020

Cataract surgery in patients with sarcoidosis-associated uveitis

1 reference

12 December 2020

Chest computed tomography and mediastinoscopy in the diagnosis of sarcoidosis-associated uveitis

1 reference

12 December 2020

Methotrexate treatment for sarcoid-associated panuveitis

1 reference

12 December 2020

Ulcerative cutaneous sarcoidosis responding to adalimumab

1 reference

12 December 2020

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

12 December 2020

Adalimumab for treatment of cutaneous sarcoidosis

1 reference

12 December 2020

Anti-TNF therapies in the management of acute and chronic uveitis

1 reference

12 December 2020

Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation

1 reference

12 December 2020

Infliximab therapy for the treatment of refractory ocular inflammatory disease

1 reference

12 December 2020

10.1007/S00417-011-1844-0

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

1 reference